baber/WOPTO huggingface dataset:
Patent JP-3412636-B2 (JP)
IPC: C30B33/02
Filed: 1991-11-11
Granted: 2003-06-03
Abstract: PCT No. PCT/IT91/00095 Sec. 371 Date May 13, 1993 Sec. 102(e) Date May 13, 1993 PCT Filed Nov. 11, 1991 PCT Pub. No. WO92/09101 PCT Pub. Date May 29, 1992.A silicon wafer containing oxygen precipitate nucleation centers (or oxygen precipitates) and having a first face, a second face, and a central plane equidistant between the first and second faces. The nucleation centers (or oxygen precipitates) have a non-uniform distribution between the first and second faces with a maximum density of the nucleation centers (or oxygen precipitates) being in a region which is between the first face and the central plane and nearer to the first face than the central plane. The density of the nucleation centers (or oxygen precipitates) increases from the first face to the region of maximum density and decreasing from the region of maximum density to the central plane.
Patent JP-H0657662-B2 (JP)
IPC: B65G53/42
Filed: 1990-12-19
Abstract: The invention relates to a pharmaceutical preparation of a non-glycosylized t-PA derivative, K1K2P pro, with an enzymatic activity of at least 0.4 MU/ml and a pH of 4.5 to 6, containing citrate and at least one compound from the following group: a) ascorbic acid, b) EDTA, c) amino compounds of formula R?1R?2N -R - X, where X = SO3?H, CH(NH2?)-CO2?H, CO2?H, H, NH2? or OH, R = C1?-C9? alkylene, C3?-C6? cycloalkylene or benzylidene and R?1 and R?2, independently of each other, are H or C1?-C3? alkyl, d) guianidinobutyric acid, e) dimethylbiguanide, f) arginine, g) glucosamine, fructose, h) pyrimidine nucleosides and pyrimidine nucleotides, i) carboxylic acids substituted with one or more hydroxyl, keto and/or further carboxyl groups. The invention also relates to a drug containing the t-PA derivative K1K2P pro as the active ingredient and a process for producing it.
Patent JP-H0463583-B2 (JP)
IPC: G03F3/08
Filed: 1987-05-01
Abstract: PCT No. PCT/DE87/00194 Sec. 371 Date Dec. 17, 1987 Sec. 102(e) Date Dec. 17, 1987 PCT Filed May 1, 1987 PCT Pub. No. WO87/06789 PCT Pub. Date Nov. 5, 1987.A method for electronic page montage for reproduction technology with recording of the pages on a recording medium by means of a recorder which comprises a multi-track recording element whose resolution is finer than the resolution of the image information, whereby, before the recording, the entire end page is divided into sub-areas within which the image information are to be recorded with the recorder in accord with a layout.
Patent JP-2636501-B2 (JP)
IPC: G02B3/00
Filed: 1991-12-06
Granted: 1997-07-30
Abstract: The present invention relates to an optical element and catadioptric optical systems using the optical element. The optical element has a spherical surface with a reflective layer formed on at least a portion of the surface, and is formed of a radiant energy transmitting material having a radial gradient index of refraction. The catadioptric optical systems include at least two optical elements at least one of which is refractive, and at least one of which has a gradient index therein. One optical system includes first and second optical elements disposed sequentially along a longitudinal axis of the system. The second optical element is the optical element with the gradient index. The first optical element is formed of a homogeneous light transmitting material and includes a spherical surface, and a reflective layer formed on a central portion of one of the spherical surface.
Patent JP-4317926-B2 (JP)
IPC: C09K11/06
Filed: 1998-06-17
Granted: 2009-08-19
Abstract: Electrolumiinescent devices with a high photoluminescent efficiency comprise a transparent conductive substrate on which is a layer of an electroluminescent material. The electroluminescent material is a rare earth metal, actinde or transition metal organic complex which has a photoluminescent efficiency of greater than 25%.
Patent JP-3246745-B2 (JP)
IPC: A61L33/00
Filed: 1994-07-13
Granted: 2002-01-15
Abstract: A medical material comprising a polymer or copolymer of a polar vinyl derivative and containing an antithrombocytic agent. Since it can release the antithrombocytic agent in an effective concentration for long, it has a high anticoagulant effect and the effect of preventing platelet loss by activating the same.
Patent JP-H0763508-B2 (JP)
IPC: A61B17/00
Filed: 1992-10-01
Abstract: A device for occluding a blood vessel comprising a helical metal coil having at least one fibrous element attached to its proximal end wherein the fibrous element(s) extends in a sinusoidal wave configuration, the loops of which extend about individual windings at spaced intervals along the axis of the coil.
Patent JP-2581788-B2 (JP)
IPC: A61P35/02
Filed: 1988-08-11
Granted: 1997-02-12
Abstract: The present invention relates to a method for treating malignancy and autoimmune disorders and for preventing allograft rejection. Conjugated or unconjugated monoclonal anti-Tac antibodies are employed to treat the above conditions. Clinical therapies have been designed to treat immune diseases and lymphomas in patients using conjugated anti-Tac antibodies.
Patent JP-2609056-B2 (JP)
IPC: C08L57/12
Filed: 1992-11-30
Granted: 1997-05-14
Abstract: An ungelled reaction product is prepared from a carboxylic acid group containing polymeric material and an azetidinol containing material having one azetidinol moiety per molecule. The ungelled reaction product is particularly useful as a grind vehicle for pigment grind compositions.
Patent JP-3120810-B2 (JP)
IPC: C07B57/00
Filed: 1993-04-01
Granted: 2000-12-25
Abstract: (S)- alpha -phenyl-2-pyridineethanamine, and its pharmaceutically acceptable derivatives, are useful in the treatment of neurodegenerative disorders, and exhibit linear pharmacokinetics.
Patent JP-3616093-B2 (JP)
IPC: C10L3/00
Filed: 1994-04-22
Granted: 2005-02-02
Abstract: The present invention generates a fuel gas which generates limited amounts of nitrogen oxides at the time of combustion, drastically increases a combustion duration time of a fuel per unit volume and can effect high temperature combustion. A primary fuel gas generated by burning a liquid fuel such as an alcohol in a fuel layer (20) of a combustion chamber (18) is mixed with a pressure air jetted from an air nozzle (16) inside a gas stream pipe (14). At this time, surrounding air entrapped in jet air forms a swirl stream. The flow passage sectional area of the primary fuel gas is first contracted with respect to the flow passage sectional area of jet air from the air nozzle (16) and is then increased, so that eddy flows occur at portions where the changes of the flow passage sectional area occur. Hydrocarbons in the primary fuel gas are decomposed into carbon and hydrogen having high activity due to the reaction of the primary fuel gas with air, and a fuel gas capable of combustion with less nitrogen oxides at a high temperature is produced. <MATH>
Patent JP-2972341-B2 (JP)
IPC: B32B27/20
Filed: 1994-04-20
Granted: 1999-11-08
Abstract: A biaxially oriented multilayer film structure comprising: (A) a core layer of polypropylene having dispersed therein microspheres sufficient in size and quantity so that, during orientation, the core layer becomes opaque, which either includes a minor proportion of a maleic anhydride modified polypropylene blended therein and/or has a skin layer (B) of maleic anhydride modified polypropylene on one side; (C) a layer of ethylene vinyl alcohol (EVOH) copolymer on the maleic anhydride modified polypropylene containing layer, and (D) on the other side of the core layer a heat sealable or printable skin layer; said structure comprising polypropylene of greater orientation in the transverse direction.
Patent JP-3995056-B2 (JP)
IPC: G07B15/06
Filed: 1996-12-18
Granted: 2007-10-24
Abstract: A method for data transfer for various applications between a on board unit (OBU), which comprises a processor, memory means and at least one interface to an external entitiy. A sequence of commands is exchanged over the interface and processed by the OBU in order to perform the respective task according to the application of the OBU and/or the external entity. The system for data transfer comprises a macro interpreter in the OBU to receive and interpret the macros from one of its interfaces.
Patent JP-3741725-B2 (JP)
IPC: A61B18/12
Filed: 1995-05-05
Granted: 2006-02-01
Abstract: An apparatus and method are provided for control contraction of tissue that includes collagen fibers. The apparatus includes a handpiece, and an electrode with an electrode proximal end associated with the handpiece. A distal end of the electrode has a geometry that delivers a controlled amount of energy to the tissue for a desired contraction of the collagen fibers. This is achieved while dissociation and breakdown of the collagen fibers is minimized. The handpiece, with electrode, is adapted to be introduced through an operating cannula in percutaneous applications. Additionally, an operating cannula may be included in the apparatus and be attached to the handpiece. The apparatus and method provides for a desired level of contraction of collagen soft tissue without dissociation or breakdown of collagen fibers.
Patent JP-3740579-B2 (JP)
IPC: B21D43/04
Filed: 1996-03-22
Granted: 2006-02-01
Abstract: Apparatus for forming elongated metal cans from relatively short cups by utilizing a reciprocating ram to drive the cups one at a time through a die pack, is provided with a continuously rotating feeder that transfers the cups from the exit of a gravity feed chute to a receiving station where each cup is indexed for engagement by the ram as it moves forward in its working stroke. The feeder rotates through one complete revolution for each forward-return cycle of the ram and during each revolution thereof a pocket in the feeder receives a cup from the chute, which cup then moves downstream through a guideway to a receiving station. Prior to being seated in a registry formation at the receiving station, the cup is engaged by a stripper that removes the cup from the feeder pocket. The feeder continues to drive the cup toward the registry formation while the cup is being stripped from the feeder pocket. A tensioner device and a formation on the feeder maintain the cup seated fully on the registry formation during the initial engagement of the cup by the ram while the latter moves forward in its working stroke.
Patent AU-2000247328-B2 (AU)
Title: Method and apparatus for compensation for time varying nozzle misalignment in a drop on demand printhead
Inventor: LAPSTON PAUL
IPC: B41J2/01
Filed: 2000-05-24
Granted: 2004-08-12
Abstract: A method of printing with overlapped segments of a segmented printhead is provided in which at least one temperature sensor on the printhead measures temperatures of adjacent segments to determine an overlapped region of the adjacent segments, an overlap signal indicative of the determined overlapped region is output from the temperature sensor to a half toning circuit, and the half toning circuit adjusts, using the received overlap signal, a half toning firing pattern of a continuous tone image for coextensive nozzles of the adjacent segments within the determined overlapped region such that VA+VB is greater than V, where VA and VB are respective independent dither matrix values of the adjacent segments and V is a continuous tone value to be represented.
Patent AU-2001248393-B2 (AU)
Title: Method and apparatus for extruding material
Inventor: KIRJAVAINEN KARI
IPC: B29C48/46
Filed: 2001-03-20
Granted: 2005-04-14
Abstract: A method and an apparatus for extruding material, the material being extruded with an apparatus comprising at least one rotatable rotor and at least one stator, the rotor and the stator comprising grooves, whereby the grooves make the material move through the apparatus when the rotor is rotated. The rotor and stator surfaces facing each other have a wavelike cross-section, and the grooves are so arranged that at the ridge of a wave the depth of a groove reaches its maximum, and at the bottom of a wave the depth reaches its minimum. The bottom of the wave in the rotor is at the ridge of the wave in the stator and vice versa. This makes the material move alternately from a rotor groove to a stator groove, and back.
Patent AU-2001260569-B2 (AU)
Title: Cataract surgery devices and methods for using same
Inventor: BEN-NUN JOSHUA DR
IPC: A61B17/00
Filed: 2001-05-20
Granted: 2005-07-21
Abstract: There are disclosed methods and apparatus for surgical removal of encapsulated tissue, and in particular removal of cataracts from lens capsules. These methods involve accessing the tissue in the capsule and maintaining control on the capsule, by gripping the capsule with an apparatus, a portion of which has been cooled, this cooling providing chilling to the apparatus portion and capsule, such that the apparatus portion adheres to the capsule by freezing. The apparatus is also heated, to limit any backwards conduction of the cooling, toward the remainder of the apparatus, with this heating keeping the apparatus at temperatures within a biocompatible range.
Patent AU-2001262621-B2 (AU)
Title: Semen analysis
Inventor: RABINOVITCH LEV
IPC: G01N21/35
Filed: 2001-05-24
Granted: 2007-03-01
Abstract: Provided is a method for measuring motile sperm concentration (MSC) in a semen sample. The method includes placing the sample in a transparent container between a light source and a photodetector thereby generating a waveform analog signal, sampling the signal so as to produce a plurality of signal samples, selecting acceptable signals and calculating the MSC based on the average of the acceptable signal samples.
Patent AU-2001267553-B2 (AU)
Title: Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
Inventor: COZZI PAOLO
IPC: A61K31/7068
Filed: 2001-06-20
Granted: 2006-02-23
Abstract: The present invention provides the combined use of acryloyl distamycin derivatives, in particular alpha-bromo- and alpha-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and antimicrotubule agents. Also provided is the use of the said combination in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogcncsis.
Patent AU-2001267593-B2 (AU)
Title: FCC reactor vessel
Inventor: FOWLER STEPHEN BRIAN
IPC: B01J8/24
Filed: 2001-07-10
Granted: 2004-03-18
Abstract: Fluidized catalytic cracking reactor vessel comprising at its upper end means to separate catalyst particles from an effluent of a dilute phase fluidized catalytic cracking reactor riser, which separation means are fluidly connected to the downstream part of the reactor riser, fluidly connected with means to discharge the cleaned reactor riser effluent from the vessel and fluidly connected to means to discharge the separated catalyst to the lower end of the vessel, the vessel further comprising at its lower end means to discharge catalyst from the reactor vessel, wherein (a) between the side wall of the vessel and the separation means a shield is present, resulting in an exterior space between the vessel wall and the shield and an interior space within the shield, wherein the interior space is in open communication with the lower end of the reactor vessel at its lower end and wherein the exterior space and interior space are fluidly connected by means of one or more openings, and (b) means are present to supply a gas poor in coke precursors to the exterior space.
Patent AU-2002328340-B2 (AU)
Title: Nucleic acid free ghost preparations
Inventor: LUBITZ WERNER
IPC: A61K39/00
Filed: 2002-07-11
Granted: 2007-06-28
Abstract: The invention relates to preparations of bacterial ghosts which are substantially free of living bacterial cells and/or nucleic acids and their use in pharmaceutical preparations.
Patent AU-2002360571-B2 (AU)
Title: Methods for improving the aesthetic appearance of skin
Inventor: PTCHELINTSEV DMITRI S
IPC: A61K31/352
Filed: 2002-12-12
Granted: 2007-04-26
Abstract: There are provided methods and compositions for improving the aesthetic appearance of akin, treating rosacea and/or telangiectasia, and treating the signs of dermatological aging. The method is directed to topically applying to an affected area an effective amount of mangostin, an analog thereof, or a combination thereof.
Patent AU-2003251286-B2 (AU)
Title: Targeted chromosomal mutagenesis using zinc finger nucleases
Inventor: GOLIC MARY M
IPC: C12Q1/68
Filed: 2003-01-22
Granted: 2007-08-16
Abstract: The present invention provides for a method or methods of targeted genetic recombination or mutagenesis in a host cell or organism, and compositions useful for carrying out the method. The targeting method of the present invention exploits endogenous cellular mechanisms for homologous recombination and repair of double stranded breaks in genetic material. The present invention provides numerous improvements over previous mutagenesis methods, such advantages include that the method is generally applicable to a wide variety of organisms, the method is targeted so that the disadvantages associated with random insertion of DNA into host genetic material are eliminated, and certain embodiments require relatively little manipulation of the host genetic material for success. Additionally, it provides a method that produces organisms with specific gene modifications in a short period of time.
Patent AU-2004215218-B2 (AU)
Title: Method and composition for injection at a tunnel boring machine
Inventor: ELLENBERGER PETER
IPC: C09K8/38
Filed: 2004-02-10
Granted: 2010-07-01
Abstract: A method of boring a tunnel by means of an earth pressure balance tunnel boring machine, comprising the injection at the cutting head of a foamed aqueous solution and an aqueous solution of a water-soluble acrylic acid-based polymer. The method allows easier tunnel boring in soft, sticky soils.
Patent AU-2005234509-B2 (AU)
Title: High efficiency organic photovoltaic cells employing hybridized mixed-planar heterojunctions
Inventor: JIANGENG XUE
IPC: H01L31/0256
Filed: 2005-04-12
Granted: 2011-07-07
Abstract: A device is provided, having a first electrode, a second electrode, and a photoactive region disposed between the first electrode and the second electrode. The photoactive region includes a first organic layer comprising a mixture of an organic acceptor material and an organic donor material, wherein the first organic layer has a thickness not greater than 0.8 characteristic charge transport lengths, and a second organic layer in direct contact with the first organic layer, wherein: the second organic layer comprises an unmixed layer of the organic acceptor material or the organic donor material of the first organic layer, and the second organic layer has a thickness not less than about 0.1 optical absorption lengths. Preferably, the first organic layer has a thickness not greater than 0.3 characteristic charge transport lengths. Preferably, the second organic layer has a thickness of not less than about 0.2 optical absorption lengths. Embodiments of the invention can be capable of power efficiencies of 2% or greater, and preferably 5% or greater.
Patent AU-2005250161-B2 (AU)
Title: Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
Inventor: KRUSE CORNELIS G
IPC: C07D233/90
Filed: 2005-05-26
Granted: 2010-10-07
Abstract: The present invention relates to 1,2,4,5-tetrasubstituted imidazole derivatives as selective cannabinoid CB1 receptor modulators, in particular CB1 receptor antagonists or inverse agonists having a high CB1/CB2 receptor subtype selectivity, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said imidazole derivatives. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. A beneficial effect is disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. The invention also relates to the use of a compound of the invention for the manufacture of a medicament for treating or preventing a disease or condition. More particularly, the invention relates to a new use for the treatment of a disease or condition disclosed herein or apparent to a person skilled in the art from the specification and general knowledge in the art. In embodiments of the invention specific compounds disclosed herein are used for the manufacture of a medicament useful in the treatment of psychiatric and neurological disorders. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification.
Patent AU-2005250211-B2 (AU)
Title: Formation of leather sheet material using hydroentanglement
Inventor: BEVAN CHRISTOPHER GRAHAM
IPC: D04H1/4274
Filed: 2005-05-27
Granted: 2010-01-21
Abstract: Leather sheet material is made by hydroentangling a web (4) of mixed reclaimed leather fibers and synthetic fibers. The synthetic fibers are meltable bicomponent fibers which are heated prior to entanglement to fuse and form a supporting network for the leather fibers. A sheet of tissue paper (1a) is laid over the surface of the leather fiber web (4) and hydroentanglement jets (16) are directed through the tissue paper into the web.
Patent AU-2006202645-B2 (AU)
Title: A method of combining letters and large-format and/or non-mechanizable postal items in a single delivery round
Inventor: GILLET FRANCOIS
IPC: B07C3/00
Filed: 2006-06-22
Granted: 2008-10-09
Abstract: The method involves passing an insert (52) carrying visual codes (53, 54) and sorting information into a sorting machine. The sorting machine is programmed to distribute the insert based on the sorting information to fragment letters (51) of a postman`s walk into several letter groups, where the insert separates the groups into two consecutive distribution points of the walk. Large and non-mechanized objects are manually inserted between the letters by marking letters using the visual codes.
Patent AU-2006242962-B2 (AU)
Title: Soft tissue support
Inventor: HAMILTON JONATHAN
IPC: A61F2/12
Filed: 2006-04-28
Granted: 2013-02-07
Abstract: The invention comprises a soft tissue support (1) in the form of a biocompatible resilient layer with a predetermined shape and means to secure the support subcutaneously. The support may be a generally L-shaped or U-shaped and be manufactured from a biocompatible resilient mesh.
Patent AU-2006268589-B2 (AU)
Title: Urea glucokinase activators
Inventor: MARIT KRISTIANSEN
IPC: C07D277/48
Filed: 2006-07-14
Granted: 2011-09-29
Abstract: The invention provides a compound of general formula (I) wherein the substituents are defined futher in the application, as well as further embodiments hereof described in the attached embodiments. The present invention also provides use of the compounds of the invention for preparation of a medicament for the treatment of various diseases, e.g. for the treatment of type 2 diabetes.
Patent AU-2006284753-B2 (AU)
Title: Method and apparatus for setting or modifying programmable parameters in power driven wheelchair
Inventor: MCCULLAR RICKY J
IPC: A61G5/04
Filed: 2006-08-31
Granted: 2013-05-02
Abstract: A collection of diagnostic and troubleshooting information associated with a power driven wheelchair is stored for access by a microcontroller to be displayed to a user to assist in troubleshooting the power driven wheelchair. A log of fault codes transmitted (G05 - 608) by various fault-detecting mechanisms is compiled. A user may request display of diagnostic information associated with a selected fault code. The operating instructions of power driven wheelchair may be updated by using portable storage media onto which a latest version of operating instructions is loaded to transfer the updated operating instructions to wheelchair controller memory. The calibration of a power driven wheelchair can be simplified by providing functionality within the wheelchair controller to change calibration parameters or to transfert calibration parameters from portable storage media.